LINDBORG STACY (EVP, Head Global Clin Research) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/13/2024ACC: 0001104659-24-034095
Officer· EVP, Head Global Clin Research
Since Jun 2020
+241.94K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
241.94K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+241.94K
Price / share
—
Trade value
—
% of position
133.3%
3/11/2024
181.50K→423.44K
Total
Net shares
+241.94K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | A · Award | +241.94K | — | — | 133.3% | 181.50K | 423.44K |
| Total | +241.94K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported